Evidence map›Paper›PMID 32783787›Full record

ArticleInfection control and hospital epidemiology2021

Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials.

Jennifer L Welch, Jinhua Xiang, Samantha R Mackin, Stanley Perlman, Peter Thorne, Patrick O'Shaughnessy, Brian Strzelecki, Patrick Aubin, Monica Ortiz-Hernandez, Jack T Stapleton

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Application of an Ultrasonic Nebulizer Closet in the Disinfection of Textiles and Footwear.International journal of environmental research and public health · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jennifer L Welch *Medical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.
Jinhua Xiang *Medical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.
Samantha R MackinDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Stanley PerlmanDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Peter ThorneDepartment of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa.
Patrick O'ShaughnessyDepartment of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa.
Brian StrzeleckiVA Puget Sound Health Care System, Seattle, Washington.
Patrick AubinCenter for Limb Loss and MoBility (CLiMB), VA Puget Sound Health Care System, Seattle, Washington.
Monica Ortiz-HernandezCenter for Limb Loss and MoBility (CLiMB), VA Puget Sound Health Care System, Seattle, Washington.
Jack T StapletonMedical Service, Iowa City Veterans' Affairs Medical Center, Iowa City, Iowa.ORCID 0000-0002-2302-9055

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
SARS-CoV Proteins in Heterologous Viral InfectionP01AI060699 · NIAID · UNIVERSITY OF IOWA · PI MCCRAY, PAUL B · 2004 to 2021
$21.5M
RESEARCH TRAINING IN INFECTIOUS DISEASEST32AI007343 · NIAID · UNIVERSITY OF IOWA · PI STAPLETON, JACK T. · 1988 to 2024
$5.0M
Role of eicosanoids in pathogenic human CoV infectionsR01AI129269 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 2016 to 2026
$4.7M
The effects of hepatitis C virus (HCV) E2 protein on host immunomodulationI01BX000207 · VA · IOWA CITY VA MEDICAL CENTER · PI STAPLETON, JACK T. · 2009 to 2025
–
BLRD VA I01 BX000207NIAID NIH HHS P01 AI060699NIAID NIH HHS R01 AI129269NIAID NIH HHS T32 AI007343NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

backgroundPersonal protective equipment (PPE) is a critical need during the coronavirus disease 2019 (COVID-19) pandemic. Alternative sources of surgical masks, including 3-dimensionally (3D) printed approaches that may be reused, are urgently needed to prevent PPE shortages. Few data exist identifying decontamination strategies to inactivate viral pathogens and retain 3D-printing material integrity.

objectiveTo test viral disinfection methods on 3D-printing materials.

methodsThe viricidal activity of common disinfectants (10% bleach, quaternary ammonium sanitizer, 3% hydrogen peroxide, or 70% isopropanol and exposure to heat (50°C, and 70°C) were tested on four 3D-printed materials used in the healthcare setting, including a surgical mask design developed by the Veterans' Health Administration. Inactivation was assessed for several clinically relevant RNA and DNA pathogenic viruses, including severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human immunodeficiency virus 1 (HIV-1).

resultsSARS-CoV-2 and all viruses tested were completely inactivated by a single application of bleach, ammonium quaternary compounds, or hydrogen peroxide. Similarly, exposure to dry heat (70°C) for 30 minutes completely inactivated all viruses tested. In contrast, 70% isopropanol reduced viral titers significantly less well following a single application. Inactivation did not interfere with material integrity of the 3D-printed materials.

conclusionsSeveral standard decontamination approaches effectively disinfected 3D-printed materials. These approaches were effective in the inactivation SARS-CoV-2, its surrogates, and other clinically relevant viral pathogens. The decontamination of 3D-printed surgical mask materials may be useful during crisis situations in which surgical mask supplies are limited.

Indexed as

MasksVirus Inactivation2-PropanolCOVID-19DecontaminationDisinfectantsDisinfectionDNA, ViralHealthy VolunteersHIV-1Hot TemperatureHumansHydrogen PeroxidePersonal Protective EquipmentPrinting, Three-DimensionalRNA, Viral2-PropanolDisinfectantsDNA, ViralHydrogen PeroxideRNA, Viral

Identifiers

PMID32783787
PMCPMC7463154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.